Philips Launches Artificial Intelligence Platform for Healthcare
|
By MedImaging International staff writers Posted on 05 Apr 2018 |

Image: The HealthSuite Insights platform is designed to give data scientists, software developers, clinicians and healthcare providers access to advanced analytic capabilities to curate and analyze healthcare data, and offers them tools and technologies to build, maintain, deploy and scale AI-based solutions (Photo courtesy of Philips Healthcare).
Royal Philips (Amsterdam, the Netherlands) has launched HealthSuite Insights, including the Insights Marketplace, to support the advancing adoption of analytics and artificial intelligence (AI) in key healthcare domains. HealthSuite Insights, which made its debut at the 2018 HIMSS Conference & Exhibition (HIMSS18), gives data scientists, software developers, clinicians and healthcare providers access to advanced analytic capabilities to curate and analyze healthcare data, and offers them tools and technologies to build, maintain, deploy and scale AI-based solutions. Insights Marketplace will provide the healthcare industry's first ecosystem where curated AI assets from Philips and others are readily available for license.
The tools and technologies available through HealthSuite Insights already enable machine learning and deep learning applications in Philips' diagnostic imaging solutions, patient monitoring solutions, and oncology and genomics offerings. The platform allows Philips to leverage AI across these innovations by combining it with other technologies and gain a deep understanding of the clinical, operational and personal context for care professionals and patients/consumers.
The Insights Marketplace will initially offer assets supplied by Philips, while medically validated Philips assets will be added later this year. It will be further expanded in late 2018 to include assets submitted by third parties. AI assets built using the Insights Platform are designed to be secure irrespective of the execution environment, with sophisticated Identity and Access Management, integrated Blockchain services, and data collection and management services built in. The Insights platform can be deployed on a healthcare cloud infrastructure such as the Philips HealthSuite Digital Platform, or on premise at a provider site.
"The quality of your AI is only as good as the quality of the data you feed into it," said Jeroen Tas, Chief Innovation & Strategy Officer Philips. "We have designed HealthSuite Insights to be used by the people who work with patient data on a daily basis and have the contextual understanding; including doctors, clinicians and hospital managers. With the HealthSuite Insights platform, we give them the ability to bring all the relevant patient information together, curate the data and use the power of AI to support precision diagnosis, personalized therapy, early intervention and greater hospital efficiency."
The tools and technologies available through HealthSuite Insights already enable machine learning and deep learning applications in Philips' diagnostic imaging solutions, patient monitoring solutions, and oncology and genomics offerings. The platform allows Philips to leverage AI across these innovations by combining it with other technologies and gain a deep understanding of the clinical, operational and personal context for care professionals and patients/consumers.
The Insights Marketplace will initially offer assets supplied by Philips, while medically validated Philips assets will be added later this year. It will be further expanded in late 2018 to include assets submitted by third parties. AI assets built using the Insights Platform are designed to be secure irrespective of the execution environment, with sophisticated Identity and Access Management, integrated Blockchain services, and data collection and management services built in. The Insights platform can be deployed on a healthcare cloud infrastructure such as the Philips HealthSuite Digital Platform, or on premise at a provider site.
"The quality of your AI is only as good as the quality of the data you feed into it," said Jeroen Tas, Chief Innovation & Strategy Officer Philips. "We have designed HealthSuite Insights to be used by the people who work with patient data on a daily basis and have the contextual understanding; including doctors, clinicians and hospital managers. With the HealthSuite Insights platform, we give them the ability to bring all the relevant patient information together, curate the data and use the power of AI to support precision diagnosis, personalized therapy, early intervention and greater hospital efficiency."
Latest Imaging IT News
- New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
- Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
- AI-Based Mammography Triage Software Helps Dramatically Improve Interpretation Process
- Artificial Intelligence (AI) Program Accurately Predicts Lung Cancer Risk from CT Images
- Image Management Platform Streamlines Treatment Plans
- AI-Based Technology for Ultrasound Image Analysis Receives FDA Approval
- AI Technology for Detecting Breast Cancer Receives CE Mark Approval
- Digital Pathology Software Improves Workflow Efficiency
- Patient-Centric Portal Facilitates Direct Imaging Access
- New Workstation Supports Customer-Driven Imaging Workflow
Channels
Radiography
view channel
AI Tool Predicts Breast Cancer Risk Years Ahead Using Routine Mammograms
Breast cancer screening saves lives but still relies largely on uniform schedules despite wide differences in individual risk. This one-size-fits-all approach can miss cancers in higher-risk women while... Read more
Routine Mammograms Could Predict Future Cardiovascular Disease in Women
Mammograms are widely used to screen for breast cancer, but they may also contain overlooked clues about cardiovascular health. Calcium deposits in the arteries of the breast signal stiffening blood vessels,... Read moreMRI
view channel
New Material Boosts MRI Image Quality
Magnetic resonance imaging (MRI) is a cornerstone of modern diagnostics, yet certain deep or anatomically complex tissues, including delicate structures of the eye and orbit, remain difficult to visualize clearly.... Read more
AI Model Reads and Diagnoses Brain MRI in Seconds
Brain MRI scans are critical for diagnosing strokes, hemorrhages, and other neurological disorders, but interpreting them can take hours or even days due to growing demand and limited specialist availability.... Read moreMRI Scan Breakthrough to Help Avoid Risky Invasive Tests for Heart Patients
Heart failure patients often require right heart catheterization to assess how severely their heart is struggling to pump blood, a procedure that involves inserting a tube into the heart to measure blood... Read more
MRI Scans Reveal Signature Patterns of Brain Activity to Predict Recovery from TBI
Recovery after traumatic brain injury (TBI) varies widely, with some patients regaining full function while others are left with lasting disabilities. Prognosis is especially difficult to assess in patients... Read moreUltrasound
view channel
Groundbreaking Technology to Enhance Precision in Emergency and Critical Care
Rapid and accurate imaging is essential for diagnosing life-threatening conditions such as myocardial infarction, heart failure, and pulmonary embolism. However, conventional ultrasound imaging of the... Read more
Reusable Gel Pad Made from Tamarind Seed Could Transform Ultrasound Examinations
Ultrasound imaging depends on a conductive gel to eliminate air between the probe and the skin so sound waves can pass clearly into the body. While the imaging technology is fast, safe, and noninvasive,... Read moreNuclear Medicine
view channel
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more
Cancer “Flashlight” Shows Who Can Benefit from Targeted Treatments
Targeted cancer therapies can be highly effective, but only when a patient’s tumor expresses the specific protein the treatment is designed to attack. Determining this usually requires biopsies or advanced... Read moreGeneral/Advanced Imaging
view channel
AI Tool Predicts Side Effects from Lung Cancer Treatment
Radiation therapy is a central treatment for lung cancer, but even carefully targeted radiation can affect surrounding healthy tissue. Patients may develop side effects such as lung inflammation, coughing,... Read more
AI Tool Offers Prognosis for Patients with Head and Neck Cancer
Oropharyngeal cancer is a form of head and neck cancer that can spread through lymph nodes, significantly affecting survival and treatment decisions. Current therapies often involve combinations of surgery,... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
Clinical imaging services face rising demand for precise molecular diagnostics and targeted radiopharmaceutical therapy as cancer and chronic disease rates climb. A new market analysis projects rapid expansion... Read more







